Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

Risk for MACE lower in adult-onset T1D versus T2D, but mortality higher from diabetic coma or ketoacidosis. (HealthDay News) — Adult-onset type 1 diabetes (T1D) is associated with an increased ...

Former President Joe Biden revealed that he has been diagnosed with prostate cancer on Friday. Biden, age 82 years, complained of urinary symptoms, which his doctors determined to be a prostate ...

Among patients with baseline HbA1c of at least 8%, phone telemedicine but not video telemedicine was associated with worse glycemic control. Higher rates of telemedicine conducted by phone are ...

Noninvasive diagnostic test measures two proteins, pTau217 and β-amyloid 1-42, found in human plasma. (HealthDay News) — The first in vitro diagnostic device that uses blood samples to detect ...

Real-world observational data show lower cardiovascular events risks during the period leading up to dialysis initiation among erythropoietin vs roxadustat users. Erythropoietin is associated with ...

Higher relapse rates were associated with c-ANCA/PR3 positivity and granulomatosis with polyangiitis phenotype. In a retrospective study of patients with antineutrophil cytoplasmic (ANCA ...

Order expected to affect specific medications covered under Medicare that are administered in a health care setting.

Surgery patients staged with PSMA-PET appear to have a lower risk of early BCR than those staged with conventional imaging. Early oncologic outcomes after radical prostatectomy (RP) for very high ...

Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

In an acute palliative care setting, intensive and comprehensive opioid management was effective for pain control without increasing doses among patients with advanced cancer. Individualized ...